Submission of certificate under Reg. 74(5) of SEBI (DP) 30.09.2024
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kobo Biotech Ltd has submitted to BSE a certificate from its Registrar and Share Transfer Agent, XL Softech Systems Ltd, confirming compliance with SEBI's Depositories and Participants Regulations for the quarter ended 30 September 2024. The certificate confirms that share certificates received for dematerialisation were duly processed, mutilated, and the depositories' names substituted in the company's register of members within 30 days. The letter is signed by Namrata Randeri, an Insolvency Professional, indicating that the company is currently under the Corporate Insolvency Resolution Process (CIRP). Notably, the filing is dated February 2026 but pertains to the quarter ending September 2024, reflecting a delay of over a year.
This is a routine procedural compliance filing with no direct impact on stock price or business operations. However, the fact that an Insolvency Professional is signing on behalf of the company is a significant red flag — Kobo Biotech remains under CIRP, meaning shareholders face ongoing uncertainty about recovery and the company's future.